FOVENTA THERAPEUTICS LIMITED

Company number 08803638 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

-£9,954,447

Balance sheet as at 2024-12-31

View full accounts →

What it does

The company continues to undertake research and development in the field of ophthalmology and other areas that use the same underlying science.

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2013-12-05
Employees
9 (2024 accounts · was 14 in 2023)
Registered office
Wtl Moorfield Road, Duxford, Cambridge, Cambridgeshire, England, CB22 4PS
Postcode
CB22 4PS
Capital
931 GBP
Accounts category
Full

Accounts

Last made up to
2024-12-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2025-12-05
Next due by
2026-12-19
View filing history →

Nature of business (SIC)

  • 21100 Manufacture of basic pharmaceutical products

Officers 7 current · 7 resigned

Olav HELLEBO Director
Appointed 2026-06-18
Phil BATES Director
Appointed 2026-03-05
Rafiq, Dr HASAN Director
Appointed 2024-05-13
John KUREK Director
Appointed 2016-11-18
Appointed 2015-09-28

View all officers and resignations →

Contact details

Website
exonate.com
Phone
01223734710, 01157840088

A biopharmaceutical company developing eyedrop treatment for Age Related Macular Degeneration wet AMD using VEGF alternative splicing.

Previous company names

NameDate changed
EXONATE LIMITED2026-08-21

Previous registered addresses 2

AddressChanged on
UNIT 23 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0EY, ENGLAND2019-06-18
C/O BEIS, SIR COLIN CAMPBELL BUILDING THE UNIVERSITY OF NOTTINGHAM, TRIUMPH ROAD, NOTTINGHAM, NG7 2TU, ENGLAND2017-02-10

Competitors Cambridge

This company ranks 12 among manufacture of basic pharmaceutical products in Cambridge.

Full league table →

The class of 2013

23%

of the 530,511 companies incorporated in 2013 are still active today; 75% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →